Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / SPONSORED ADR NE
-
Total 13F shares
-
239,213
-
Share change
-
+134
-
Total reported value
-
$241,734
-
Price per share
-
$1.01
-
Number of holders
-
5
-
Value change
-
+$136
-
Number of buys
-
1
-
Number of sells
-
1
Institutional Holders of XTL BIOPHARMACEUTICALS LTD - SPONSORED ADR NE (XTLB) as of Q4 2023
As of 31 Dec 2023 XTL BIOPHARMACEUTICALS LTD - SPONSORED ADR NE (XTLB) had 5 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 239,213 shares of stock of the company.
Largest 5 holders included Noked Israel Ltd, MORGAN STANLEY, BNP PARIBAS FINANCIAL MARKETS, CENTRAL TRUST Co, and UBS Group AG.
This table shows 5 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.